ANTICARDIOLIPIN ANTIBODIES IN EYE AND NON-EYE MANIFESTATIONS OF VASCULAR DISTURBANCES IN PATIENTS WITH BEHCET’S DISEASE
https://doi.org/10.14412/1995-4484-2000-1230
Abstract
Aim: Determining of possible relations between the presence of anticardiolipin antibodies (АСА) and occlusional thrombotic manifestations of Behcet’s disease(BD) Material and methods: Results of АСА study in 31 pts with BD depending on eye and other forms of occlusion or vascular thrombosis. Results: Increased АСА titers were found in 16.6% of pts and all of them belonged to the group with thrombosis of other than eye localization. No АСА was found in pts with isolated occlusional processes in fundus of the eye, in pts with combined occlusions of retinal vessels and thromboses of other then eye localization and also in pts without occlusional and thrombotic processes. Median level of АСА IgG was the highest also in BD pts with other than eye thrombosis (20.0±10.8 GPL). In pts with isolated occlusion of retinal vessels and pts without occlusional processes the level of median АСА IgG values was reliably lower (correspondingly 9,4±4,2 GPL, p<0,01; 6,9±6,4 GPL, p<0.01). Median АСА IgM level was higher in pts with simultaneous occlusion of retinal vessels and vascular thrombosis of other than eye localization (11,4±6,4 GPL, p<0,01). The lowest median level oj АСА IgM was observed in pts with isolated occlusion of retinal vessels (6,5±33,9 MPL). but the differences between groups of pts in АСА IgM determination were not statistically reliable. Conclusion: The obtained data enable us to suppose that АСА do not play a significant role in the development of occlusion of retinal vessels during BD.
References
1. <div><p>Алекберова З.С., Прокаева Т.Б., Решетняк Т.М., Александрова Е.Н., Насонов Е.Л. Антифосфо- липидные антитетала при болезни Бехчета. Клин, мед., 2000, 5. 37-38.</p><p>Glacet Bernard A. et al. Antiphospholipid amtibodies in retinal vascular occlusions. Arch Ophthalmol., 1994,112,790-795.</p><p>Gregson R.M.C, Merry P., Schulenburg W.E. Vaso-occlusive retinopathy in primary antiphospholipid antibody syndrome. Eye, 1991, 5, 48-55.</p><p>Jonas J., Kolble K. Faiden J.R. '“Central retinal artery occlusion in sneddon's disease associated with antiphospholipid antibodies”. Am. J. Ophthalmol., 1986. 102,37-40.</p><p>Levine S.R. et al. Visual symptoms with the presense of lupus anticoagulant. Ophthalmology, 1988, 95, 686-692.</p><p>Mader R., Ziv М., Adawi М., Lavi I. Thrombo- phylic factors and their relation to thromboembolic and clinical manifestations in Behcet’s Disease. 8-th International Congress on Behcet’s Disease. Reggio Emilia, October 7-9, 1998, 166.</p><p>Priori R., Conti F., Pittoni V., Accorinti М., Cava M.La, Carofalo Т., Sorice M, Valesini G. Anti-phospholipid-binding protein antibodies in Behcet’s disease. 8-th International Congress on Behcet’s Disease. Reggio Emilia. October 7-9, 1998, 168.</p><p>Reisin L.H., Reisin I., Darawshi A., Aiel E. Central retinal artery occlsion in a patients with circulating lupus anticoagulant. Ann. Ophthalmol., 1989, 21, 269-271.</p><p>Sielman A. Criteria for diagnosis of Behcet’s disease. EULAR Bulletin, 1991, XX, 1, 5-7.</p><p>Watts M.T., Greaves М., Rennie I.G., Clear- kin L.G. Antiphospholipid antibodies in the aetiology of ischaemic neuropathy. Eye, 1991, 5,75-79. ll.Zitouni M. Houman M.H. Ghorbel B., Lamloum М., Sellami N., Miled М., Makni S. Anticardiolipin and beta 2 glycoprotein I autoantibodies in Behcet’s disease. 8-th International Congress on Behcet’s Disease. Reggio Emilia, October 7-9, 1998, 173.</p></div><br />
Review
For citations:
Ermakova N.A., Alekberova Z.S., Nassonov E.L. ANTICARDIOLIPIN ANTIBODIES IN EYE AND NON-EYE MANIFESTATIONS OF VASCULAR DISTURBANCES IN PATIENTS WITH BEHCET’S DISEASE. Rheumatology Science and Practice. 2000;38(2):27-30. (In Russ.) https://doi.org/10.14412/1995-4484-2000-1230
Views:
681
Email this article 